Derek Small - Assembly Biosciences Insider

ASMB -- USA Stock  

USD 43.55  2.00  4.81%

Co-Founder, CEO and President and Director
Mr. Derek A. Small is President, Chief Executive Officer, Director of ASSEMBLY BIOSCIENCES, Inc. Mr. Small is a cofounder of Assembly Pharmaceuticals, and has served as Executive Chairman of the company since inception in 2012. From March 2008 to January 2014, Mr. Small served as a founding director, President, and Chief Executive Officer of Naurex, Inc., a privately held biotechnology company. From January 2009 to April 2012, Mr. Small also served as founding director, President, and Chief Executive Officer to Coferon, Inc., a privately held biotechnology company. Each of these companies was founded as portfolio companies of Luson Bioventures, a biotechnology and biopharmaceutical venture creation firm that Mr. Small founded in 2007. Mr. Small continues to serve on the Board of Directors of Naurex, Inc
Age: 38  CEO Since 2015      
317-210-9311  http://www.assemblybio.com
Small received his BS in Business from Franklin College, including participation in the Harlaxton College affiliate program in England.

Management Efficiency

The company has return on total asset (ROA) of (23.67) % which means that it has lost $23.67 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (53.01) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 11 records

CEO Since

Jeffrey BachaDelMar Pharmaceuticals
2018
Ting ZhengChina Cord Blood Corporation
2017
Eddie GrayDynavax Technologies Corporatio
2013
Ron EllisEndocyte
1996
Douglas FambroughDicerna Pharmaceuticals
2013
Alex SapirDova Pharmaceuticals
2017
Brian LeuthnerEdge Therapeutics
N/A
Ryan WattsDenali Therapeutics
2016
Yue DengChina Cord Blood Corporation
N/A
Barry SimonNantKwest
2017
Rui ArashiyamaChina Cord Blood Corporation
N/A

Entity Summary

Assembly Biosciences, Inc. operates as a clinical stage biotechnology company. Assembly Biosciences, Inc. was founded in 2005 and is headquartered in Carmel, Indiana. Assembly Biosciences operates under Biotechnology classification in USA and traded on Nasdaq Capital Markets. It employs 85 people.Assembly Biosciences (ASMB) is traded on BATS Exchange in USA. It is located in NEW YORK U.S.A and employs 85 people. Assembly Biosciences was previously known as ASSEMBLY BIOSCIENCES INC and was traded on BATS Exchange under the symbol VTUS. Assembly Biosciences is listed under Pharmaceutical Products category by Fama And French industry classification.

Assembly Biosciences Leadership Team

Uri Lopatin, President, Ph.D
Helen Kim, Director, MBA
Myron Holubiak, Director
Lee Arnold, Executive, Ph.D
Anthony Altig, Director
Richard Colonno, Executive
Graham Cooper, COO, MBA
William Ringo, Chairman, MBA
Susan Mahony, Director
Richard DiMarchi, Director, Ph.D
Miguel Barbosa, Executive, Ph.D
Thomas Rollins, Executive
Mark Auerbach, Director
Derek Small, CEO
Alan Lewis, Director, Ph.D
David Barrett, COO

Stock Performance Indicators

Did you try this?

Run Volatility Analysis Now
   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Volatility Analysis

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Assembly Biosciences and China Cord Blood. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Check also Trending Equities. Please also try Portfolio Manager module to state of the art portfolio manager to monitor and improve performance of your invested capital.